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INTRODUCTION
Gastrectomy with lymph node (LN) dissection was con-
sidered as the only standard treatment of early gastric cancer 
(EGC) in the past, but a curative endoscopic treatment is 
widely used recently. Endoscopic treatment of EGC is less in-
vasive than surgery, reduces medical costs, improves quality 
of life of patients, and is as effective as surgery. Endoscopic 
treatment for EGC is performed more frequently with the 
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increased detection of EGC by universal health check-ups. 
But curative endoscopic mucosal resection of EGC was per-
formed only in selected cases depending on the differentia-
tion, size and depth of invasion of their lesions. Traditional 
indication of endoscopic treatment was an elevated type can-
cer of less than 2 cm in size (EGC І or ІІa) and a depressed 
type of less than 1 cm without ulcer (EGC ІІc) among differ-
entiated EGCs confined to the mucosa.
1 This was to mini-
mize the possibility of LN metastasis and local recurrence. 
With the recent development of endoscopic maneuver and 
the accessory tools, the introduction of endoscopic submu-
cosal dissection (ESD) enabled endoscopic treatment of le-
sions deemed untreatable in the past. ESD improved en bloc 
resection rate and complete resection rate regardless of the 
lesions location and size, compared to the conventional en-
doscopic mucosal resection. ESD also enabled dissection of 
submucosal layer as deep as 1,500 µm and extended the indi-
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cation of endoscopic treatment regardless of the size, loca-
tion, and shape of lesions, which were limitations of the con-
ventional endoscopic treatment.
2 ESD still cannot be 
performed confidently in undifferentiated or submucosal in-
vasive (SM) EGC, though. Such lesions favor surgery than 
endoscopic treatment due to the increased frequency of local 
recurrence, micro-invasion, and LN metastasis.
3,4 
But accurate assessment of depth of invasion is difficult in 
pre-ESD lesion. When using endoscopic ultrasonography 
(EUS) and conventional endoscopy together, accuracy of in-
vasion depth is about 90% on the lesion confined to mucosa 
only, about 70-80% on deeper lesions, particularly SM 1 le-
sion is very difficult to detect due to its depth is slight.
5 There 
might be also a difference between the endoscopic biopsy re-
sult before the endoscopic treatment and the histologic find-
ings after the treatment, such as that a differentiated EGC 
before the endoscopic treatment was often confirmed as un-
differentiated after the treatment.
6,7 Such pathologic findings 
after the treatment requires decision about additional treat-
ment or surgery, but currently there is no definite criteria for 
such occasions.
This study was performed to investigate the clinical course 
of cases confirmed as undifferentiated or SM EGC according 
to the pathologic findings after ESD. Local recurrent cases 
were analyzed to determine the cases who need additional 
treatment or surgery and who are available for follow-up.
MATERIALS AND METHODS
Patients
Among 210 cases of ESD due to EGC at our hospital be-
tween August 2005 and August 2009, 41 cases were SM le-
sions and 18 cases were undifferentiated lesions according to 
the pathologic reports after the ESD. A retrospective study 
was performed in these cases based on their medical records.
Methods
The indication of ESD included well or moderate differen-
tiation from biopsy, mucosal cancer (M cancer) from endo-
scopic gross findings, and cases without prominent ulcer on 
the surface of the lesion. Patients rejecting the surgery or 
with unsuitable condition for surgery also received ESD even 
though the lesion is undifferentiated or invading SM1 from 
endoscopic gross finding. Pathology of pre-ESD was checked 
from the biopsy reports of our hospital or other hospitals. 
Abdominal computed tomography (CT) was performed in 
every patient to confirm the absence of distant metastasis or 
local LN metastasis.
En bloc resection was attempted whenever possible, and 
the resected surfaces were sliced at 2 mm intervals to con-
firm the complete resection, which was defined by no histo-
logical tumor cell in the margin and no tumor emboli in 
lymphovascular space. Rates of en bloc resection and com-
plete resection were analyzed. Submucosal layer of the re-
sected tissue was divided in 3 equal parts and an invasion 
less than 500 µm was classified as SM1, more than 500 µm as 
SM2, or as SM3.
8 EGC was classified as differentiated adeno-
carcinoma when the lesion was well differentiated or moder-
ately differentiated, or as undifferentiated when the lesion 
was poorly differentiated or a signet ring cell cancer.
Follow-up endoscopy and biopsy was performed at 3, 6, 
and 12 months after the treatment, and annual follow-up en-
doscopy and abdomen CT was performed thereafter if not 
showing other abnormality. The period of follow-up endos-
copy was adjusted in some cases based on the clinician’s deci-
sion. Additional biopsy was performed to confirm the pres-
ence of residual lesion when histologic tumor cell was found 
at the margin of the resected lesion. So, the follow-up was 
continued as planned when there was no residual lesion, but 
the surgery was performed when a residual lesion was found.
Statistical analysis
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was used 
for statistical analysis. Chi-square test was used for univariate 
analysis of factors associated with local recurrence and the 
comparison of differentiated and undifferentiated cancer, 
and mucosal and SM cancer. Logistic regression analysis was 
performed for multivariate analysis of factors associated with 
local recurrence. p-value less than 0.05 was determined sta-
tistically significant.
RESULTS
Pathologic results of EGC treated by ESD
Pathologic result after ESD was confirmed as differentiated 
cancer in 192 lesions (91.4%) and undifferentiated cancer in 
18 lesions (8.6%). Among 18 lesions of undifferentiated can-
cer, 8 lesions were determined undifferentiated, 9 lesions dif-
ferentiated, and 1 lesion adenoma by pre-ESD pathology 
(Fig. 1). One hundred sixty-nine lesions (80.5%) were local-
ized to the mucosa, 35 lesions (16.7%) were SM1 invasion, 
and 6 lesions (2.8%) were SM2 invasion. En bloc resection 
rate was 80.5% (169 lesions) and the complete resection rate 
was 86.2% (181 lesions) (Table 1).
Characteristics of undifferentiated EGC  
treated by ESD
EGC was differentiated in 192 lesions and undifferentiated 
in 18 lesions. Undifferentiated cancer had larger tumor size 
and significantly more submucosal invasion and lymphovas-118  Clin Endosc 2011;44:116-122
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cular tumor emboli (LVTE) than differentiated cancer. Posi-
tive rate of resected margin was significantly higher in undif-
ferentiated cancer, leading to a significantly lower complete 
resection rate (10/18, 55.6%). Among 8 lesions with incom-
plete resection, 4 lesions were positive vertical margin, 1 le-
sion positive horizontal margin, and 1 lesion positive both 
vertical and horizontal margin. Two lesions had positive 
LVTE. There was no difference between the en bloc resection 
rates of the two groups (Table 2).
Characteristics of EGC with submucosal  
invasion treated by ESD
One hundred sixty-nine lesions were determined as M 
cancer and 41 lesions were submucosal invasion. EGC with 
submucosal invasion had larger tumor size and significantly 
more undifferentiated and LVTE positive than M cancer. 
Positive rate of resection margin was significantly higher in 
EGC with submucosal invasion, leading to a lower complete 
resection rate (36.6%) compared to M cancer (98.8%). 
Among 26 lesions with incomplete resection, 14 lesions were 
positive vertical margin, 2 lesions were positive horizontal 
margin, and 10 lesions were positive LVTE. There was also 
no significant difference between the en bloc resection rates 
of the two groups (Table 3).
Clinical outcomes of EGC treated by ESD
The mean follow-up period among 191 patients who were 
available for follow-up was 19.39±11.2 months. No regional 
LN enlargement or distant metastasis suggesting recurrence 
was found at follow-up abdomen CT. Local recurrence was 
confirmed in 4 lesions (2%) by endoscopic biopsy during 
follow-up. One case (0.6%) had recurrence among 164 cases 
with M cancer available for the follow-up. 
Table 1. General Clinical Outcomes for EGC Treated by ESD
Clinical outcome No. of patients (%)
Total patients  210
F/U loss  8 (3.8)
Salvage operation  11 (5.2)
Total F/U lesions  191 (91)
Post ESD Pathology 
Well or moderate differentiated  192 (91.4)
Undifferentiated  18 (8.6)
Post ESD invasive depth 
Mucosa  169 (80.5)
Submucosa 1 layer  35 (16.7)
Submucosa 2 layer  6 (2.8)
En bloc resection  169 (80.5)
Piecemeal resection  41 (19.5)
Complete resection  181 (86.2)
Incomplete resection  29 (13.8)
EGC, early gastric cancer; ESD, endoscopic submucosal dissec-
tion; F/U, follow-up.
Table 2. Comparison of Clinicopathologic Features between Dif-
ferentiated and Undifferentiated EGC after ESD
Clinicopathologic 
feature
Depth of invasion
p-value Mucosa
(n=169) 
Submucosa
(n=41)
Age, yr 65.89±10.28 66.6±9.7
Sex
Male 114 (67.5) 31 (75.6) 0.311
Female 55 (32.5) 10 (24.4)
Gross type
Elevated  42 (24.9) 15 (36.6) 0.186
Flat 5 (3.0) 0 (0)
Depressed 122 (72.2) 26 (63.4)
Tumor size, cm
1≥ 88 (52.1) 9 (22.0) 0.000
1≤/<2 61 (36.1) 20 (48.8)
2≤/<3 13 (7.7) 6 (14.6)
≥3 7 (4.1) 6 (14.6)
Differentiation
Differentiated  159 (94.1) 33 (80.5) 0.005
Undifferentiated 10 (5.9) 8 (19.5)
LVTE
Positive  0 (0) 19 (46.3) 0.000
Negative 169 (100) 22 (53.7)
Resection margin
Positive  4 (2.4) 16 (39.0) 0.000
Negative 169 (97.6) 25 (61.0)
Values are presented as mean±SD or number (%).
EGC, early gastric cancer; ESD, endoscopic submucosal dissec-
tion; LVTE, lymphovascular tumor emboli.
Fig. 1. Pre-endoscopic submucosal dissection (ESD) pathologic 
diagnosis of the patients with undifferentiated cancer confirmed 
by ESD.
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One case (4.1%) out of 24 cases with SM1 invasive cancer 
were also recurred. There was a statistically significant differ-
ence in the recurrence rates between M cancer and SM1 in-
vasive cancer (p=0.001). Three cases that were SM2 invasion 
but the patients rejected the surgery were followed, and 2 
cases (66.6%) among them had recurrence. There was also 
statistically significant difference in the recurrence rates be-
tween SM1 and SM2 invasive cancer (p=0.025). One case 
(0.5%) among 177 cases of differentiated cancer and 3 cases 
(21.4%) among 14 cases of undifferentiated cancer had recur-
rence, with statistically significant difference between the two 
(p=0.001) (Table 4). 
When both differentiation and depth of invasion were 
considered, 154 cases (80.6%) with differentiated M cancer 
did not experience recurrence, while 1 case (10%) among 10 
(5.2%) undifferentiated M cancer cases had recurrence, and 
there was no statistically significant difference between the 
two groups (p=0.061). Among 22 cases (11.5%) of differenti-
ated SM1 cancer, 1 case (4.5%) experienced recurrence, 
without significant difference with the differentiated M can-
cer group (p=0.125). But 2 case (50%) among 4 cases of un-
differentiated SM cancer were recurred with significant dif-
ference with the differentiated M cancer group (p=0.000) 
(Table 5).
Clinicopathologic characteristics of locally  
recurred EGC lesions after ESD
Local recurrence was confirmed at 4 lesions during follow-
up after ESD; 2 lesions were undifferentiated EGC, and 3 le-
sions were SM cancer. One lesion was undifferentiated EGC 
Table 3. Comparison of Clinicopathologic Features according to 
Invasive Depth of EGC after ESD
Clinicopathologic 
feature
Depth of invasion
p-value  Mucosa
(n=169)
Submucosa
(n=41)
Age, yr  65.89±10.28 66.6±9.7
Sex
Male 114 (67.5) 31 (75.6) 0.311
Female 55 (32.5) 10 (24.4)
Gross type
Elevated 42 (24.9) 15 (36.6) 0.186
Flat 5 (3.0) 0 (0)
Depressed 122 (72.2) 26 (63.4)
Tumor size, cm
1≥ 88 (52.1) 9 (22.0) 0.000
1≤/<2 61 (36.1) 20 (48.8)
2≤/<3 13 (7.7) 6 (14.6)
≥3 7 (4.1) 6 (14.6)
Differentiation
Differentiated 159 (94.1) 33 (80.5) 0.005
Undifferentiated 10 (5.9) 8 (19.5) 
LVTE
Positive 0 (0) 19 (46.3) 0.000
Negative 169 (100) 22 (53.7)
Resection margin
Positive 4 (2.4) 16 (39.0) 0.000
Negative 169 (97.6) 25 (61.0)
Curability
Complete resection 167 (98.8) 15 (36.6) 0.000
Incomplete resection 2 (1.2) 26 (63.4)
En bloc resection
Yes 138 (81.7) 31 (75.6) 0.381
No 31 (18.3) 10 (24.4)
Values are presented as mean±SD or number (%).
EGC, early gastric cancer; ESD, endoscopic submucosal dissec-
tion; LVTE, lymphovascular tumor emboli.
Table 4. Follow-Up Results of the Patients Treated by ESD Vari-
able
Variable
No. of  
patients (%)
No. of  
recurrence (%)
p-value
Total F/U patients  191
Mean F/U period, mo  19.39±11.2
F/U abdominal CT  191 0 (0)
F/U EGD  191 4 (2)
M cancer  164 (85.9) 1 (0.6) 0.001
SM1 cancer  24 (12.6) 1 (4.1) 0.025
SM2 cancer  3 (1.5) 2 (66.6)
Differentiated  177 (92.6) 1 (0.5)
Undifferentiated  14 (7.4) 3 (21.4) 0.001
ESD, endoscopic submucosal dissection; F/U, follow-up; CT, com-
puted tomography; EGD, esophagogastroduodenoscopy; M, mu-
cosa; SM1, submucosal 1 layer; SM2, submucosal 2 layer.
Table 5. Local Recurrence Rate according to Differentiation and 
Invasive Depth 
Variable
No. of  
patients  
(%)
No. of local 
recurrence 
(%)
p-value
M cancer & Diff 154 (80.6) 0 (0)
M cancer & Undiff  10 (5.2) 1 (10) 0.061
Diff & M cancer  154 (80.6) 0 (0)
Diff & SM1 cancer  22 (11.5) 1 (4.5) 0.125
M cancer & Diff  154 (80.6) 0 (0)
SM cancer & Undiff  4 (2) 2 (50) 0.000
M, mucosa; Diff, differentiated cancer; Undiff, undifferentiated 
cancer; SM1, submucosal 1 layer.120  Clin Endosc 2011;44:116-122
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confined to the mucosa, which was completely resected but 
recurred at 31 months after the ESD. Table 6 shows the addi-
tional treatments applied and pathologic stages after the sur-
gery of these cases.
Factor affecting local recurrence in post ESD lesions
When the recurrence rate was subdivided by the depth of 
invasion, the recurrence rate was 0.6% (1/164) for EGC con-
fined to the mucosa, 4.1% (1/24) for SM1, and 66.6% (2/3) 
for SM2, indicating an increasing pattern with deeper inva-
sion. The recurrence rate of undifferentiated cancer was 
21.4% (3/14), significantly higher than 0.5% (1/177) in dif-
ferentiated cancer. Positivity of resection margin and the size 
of the lesion also affected the local recurrence, but only the 
differentiation was an independent factor at multivariate 
analysis, significantly affecting the local recurrence (Table 7).
DISCUSSION
Undifferentiated or SM EGC is still limited from endo-
scopic treatment, despite recent development of ESD, and 
only carefully discussed based on a few studies.
9,10 Assess-
ment of LN metastasis before endoscopic resection is impor-
tant for endoscopic treatment of EGC, which was reported as 
0.4% in differentiated M cancer and 4.2% in undifferentiated 
M cancer.
11 This difference becomes an important criteria 
when selecting a candidate patient for mucosal resection. In 
addition to the high LN metastasis rate, undifferentiated 
EGC is more likely to invade submucosal layer even in small 
size and distributed in subepithelial lateral spreading or dis-
continuous pattern, which meant that an endoscopic treat-
ment was not easily applicable due to the difficulty of defin-
ing definite lesion area before the ESD.
11-13 EGC with 
submucosal invasion was also excluded from the indication 
of ESD because of high (10-25%) frequency of LN metasta-
sis.
14,15 Undifferentiated or SM EGC were candidates of sur-
gery rather than endoscopic treatment, for these reasons.
The existing indication on endoscopic resection of EGC is 
based on surgical data, which were more focused on the 
probability of LN metastasis. These indications, however, did 
not consider actual problems associated with endoscopic 
procedures, such as incomplete resection, which could be 
more important problems particularly in undifferentiated 
cancer or SM cancer.
9 This study has the meaning in that un-
differentiated or SM cancer after ESD were investigated.
The complete resection rate 55.6% among 18 cases con-
firmed as undifferentiated cancer after ESD was significantly 
lower than 89.1% in differentiated cancer. This result was 
comparable with other studies reporting clinical outcomes of 
ESD in undifferentiated cancer.
16 It is possible, as mentioned 
earlier, that the actual size and depth of the lesion was larger 
than expected before ESD due to the characteristics of undif-
ferentiated cancer.
16 The complete resection rate (36.6%) of 
41 cases of SM cancer was also lower than that of M cancer 
(98.8%), reflecting the fact that complete resection of SM 
cancer is more difficult than M cancer. These actual prob-
lems associated with procedure, such as incomplete resec-
tion, are other reasons why ESD is difficult in undifferentiat-
ed or SM EGC.
Local recurrence was confirmed in 4 cases (2%) at follow-
up endoscopic biopsy among 191 patients available for fol-
low-up after ESD. Another study on ESD for EGC reported 
3.7% for recurrence rate.
17 When these cases were analyzed ba-
sed on their depth of invasion and differentiation, the recur-
rence rate was higher when the lesion was deeper and undif-
ferentiated, probably because the complete resection rate is 
decreased in such cases, as mentioned earlier. This study re-
ported relatively higher recurrence rate (21.4%) after ESD for 
undifferentiated cancer compared to that reported by anoth-
er study (5.1%), probably because 2 out of 3 recurrent cases 
were resected incompletely.
9
Like this, ESD is difficult to apply in SM or undifferentiat-
ed EGC. The important problem is that the discrepancy of 
differentiation before and after the ESD frequently occurs 
and there is the difficulty of predicting the depth of tumor 
invasion accurately. Even the EUS using to evaluate the depth 
Table 6. Clinicopathologic Characteristics of Locally Recurred EGC Lesions after ESD
Patients
(n=4) 
Endoscopic 
finding
Tumor
size
Histologoic
differentia-
tion
Depth of
invasion
LVTE
Resection
margin
En bloc
resection
Time to
recurrence, 
mo
Salvage
treatment
Post op
staging
Post op
treatment
56/Male  Depressed 1≤/<2 UD M (-) (-) Yes 31 F/U loss -
81/Male  Elevated ≥3 UD SM2 (+) (+) No 4 STG No tumor (-)
66/Male  Elevated 2≤/<3 D SM1 (-) (-) Yes 9 STG T1NoMo (-)
65/Female  Depressed ≥3 UD SM2 (-) (+) Yes 10 STG T2N1Mo Oral CTx
EGC, early gastric cancer; ESD, endoscopic submucosal dissection; LVTE, lymphovascular tumor emboli; op, operation; UD, undifferentiat-
ed; M, mucosa; F/U, follow-up; SM2, submucosal 2 layer; STG, subtotal gastrectomy; D, differentiated; SM1, submucosal 1 layer; CTx, che-
motherapy.PG Goh et al. 
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of invasion accurately before ESD shows similar accuracy as 
endoscopic gross findings. Only 90% of accuracy in EUS 
produced by combined with endoscopic gross finding in M 
cancer.
5 Also, a previous study reported 23.7% of discrepancy 
in differentiation,
6 and only 50% among undifferentiated pa-
tients before ESD were diagnosed as undifferentiated cancer 
again after ESD in this study. This discrepancy in the histo-
logical diagnosis may be explained by the fact that endo-
scopic biopsy is collected from only a part of lesion and the 
histologic type is determined by the dominant type among 
multiple histologic types.
6 
When the pathologic result after ESD diverged from the 
conventional indication, additional procedure or salvage op-
eration should be considered. Some studies reported the 
possibility of endoscopic treatment of undifferentiated can-
cer, and even the possibility of endoscopic treatment of EGC 
with SM1 invasion. It is suggested, therefore, that surgery is 
not always the best choice for cases not indicated for endo-
scopic treatment, considering the increased risk of surgery 
with comorbid diseases and the patient’s quality of life after 
the surgery. We evaluated the cases that were available to fol-
low-up after ESD and cases that had to consider salvage op-
eration early with respect to their local recurrence. Com-
pared to the case with differentiated EGC confined to the 
Table 7. Univariate and Multivariate Analysis of Factors Affecting Local Recurrence in Post ESD Lesions
Variable No. of patients (%) No. of local recurrence (%)
p-value
Univariate  
analysis
Multivariate 
analysis
Sex 1.00
Male  130 (68) 3 (2.3)
Female 61 (32) 1 (1.6)
Encoscopic finding 0.330
Elevated 52 (27.2) 2 (3.8)
Flat 5 (2.6) 0 (0)
Depressed 134 (70.2) 2 (1.4)
Tumor size, cm 0.000 0.571
<1 91 (48.2) 0 (0)
1</<2 71 (37.2) 1 (1.4)
2</<3 17 (8.9) 1 (5.9)
>3 11 (5.8) 2 (18.2)
Margin involvement 0.011 0.725
Negative 182 (95.2) 2 (1.0)
Positive 9 (4.8) 2 (22.2)
En bloc resection 0.569
Yes 155 (81.2) 3 (1.9)
No 36 (18.2) 1 (2.8)
Invasion depth 0.001 0.218
M 164 (85.9) 1 (0.6)
SM1 24 (12.6) 1 (4.1)
SM2 3 (1.5) 2 (66.6)
Histology 0.001 0.019
Differentiated 177 (92.6) 1 (0.5)
Poorly differentiated 14 (7.4) 3 (21.4)
LVTE
Positive 180 (94.2) 3 (1.7) 0.213
Negative 11 (5.8) 1 (9.1)
ESD, endoscopic submucosal dissection; M, mucosa; SM1, submucosal 1 layer; SM2, submucosal 2 layer; LVTE, lymphovascular tumor em-
boli.122  Clin Endosc 2011;44:116-122
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mucosa that did not have local recurrence, cases with undif-
ferentiated EGC confined to the mucosa and cases with dif-
ferentiated EGC with SM1 invasion did not show statistically 
significant difference in their local recurrence rates. The cases 
with undifferentiated EGC with SM invasion showed recur-
rence rate as high as 50%. This result suggests that cases of 
undifferentiated EGC with SM invasion requires early sal-
vage operation, while cases of undifferentiated EGC confined 
to the mucosa or differentiated EGC with SM1 invasion 
could be better to wait and see with short-term follow-up 
rather than to perform salvage operation immediately. Al-
though there is a risk of missing the opportunity of complete 
cure, careful short-term follow-up could be possible for well-
selected patients, considering the increased risk of surgery 
with comorbid diseases and the patient’s quality of life after 
the surgery. Additionally, among 11 patients who received 
early salvage operation after ESD in this study, only 3 patients 
had residual tumor, 8 patients did not have any residual tu-
mor, and regional LN metastasis was detected only in 1 pa-
tient. This result is similar to the positive rate of residual tu-
mor (32.5%) reported from other studies that performed 
surgery after endoscopic resection.
18 
In addition to the depth of invasion and differentiation, 
size of tumor and positive tumor cell of resection margin 
were also factors associated with local recurrence of post-
ESD lesion. Multivariate analysis revealed differentiation was 
the only independent factor affecting local recurrence. Other 
studies reported positive tumor cell of resection margin, the 
depth of invasion, or the size of tumor as independent fac-
tors affecting the local recurrence.
16,17,19 It seems the small 
size of our study was the reason of different result with other 
studies. This study has several limitations including that the 
assessment of LN metastasis was evaluated only by radiologic 
findings except for patients who received surgery, the follow-
up period was not long enough, the number of enrolled pa-
tients were small, and designed as a retrospective study.
In conclusion, undifferentiated or with SM invasion EGC 
shows low complete resection rate and high local recurrence 
rate after ESD. When the EGC was diagnosed as undifferen-
tiated or SM invasion after ESD, it is required to decide 
whether or not perform immediate salvage operation, but a 
short-term follow-up could be possible if the lesion was 
completely resected and reported as undifferentiated EGC 
confined to the mucosa or differentiated EGC confined to 
the SM1. This needs further studies in larger patient groups. 
Immediate salvage operation is more advisable, however, for 
undifferentiated EGC with SM invasion.
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